Trial intelligence / Profile preview

ZiPhenol: Zinc and Green Tea for Respiratory Viral Infections

NCT04898023Phase 2Terminated

Sponsor
University of Missouri
Start
Sep 2022
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Zinc citrate, green tea extract, ascorbic acid in respiratory viral infection, sponsored by University of Missouri. Started Sep 2022; status: terminated.

02

Drugs

Zinc citrategreen tea extractascorbic acid
03

Conditions

respiratory viral infection

Beyond the preview

Go deeper on NCT04898023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04898023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call